Key Takeaways
- • Ares Management Corp. (ARES) declined 5.18% on April 27, 2026, reaching an intraday low of $112.64, reflecting significant near-term price pressure in the alternative asset management sector.
- • Year-to-date performance stands at -28.99%, substantially underperforming the S&P 500's +3.84% gain, while the stock has fallen 21.36% over the trailing one-year period versus the index's 32.23% appreciation.
- • Despite current weakness, the company maintains strong operational fundamentals, including an 18.63% average return on equity and positive results across the last three consecutive quarters, supporting long-term investor conviction.
- • Analyst price targets show divergence, with Argus lowering its target to $107.00 while other analysts maintain a "Buy" rating with 12-month upside targets near $141.71, indicating 25.40% potential upside from current levels.
- • Recent February 2025 earnings results included worse-than-expected Q4 2025 performance, triggering an 11.2% single-day decline and contributing to sustained headwinds throughout the first quarter of 2026.
Summary
Ares Management Corp. experienced a challenging trading session on April 27, 2026, as the alternative asset manager's stock fell 5.18% to close near its intraday low of $112.64. The decline reflects ongoing market pressure on the mid-cap financial services firm, which operates as a significant player in the capital markets and asset management industry.
The stock's performance reveals a stark divergence between near-term and long-term trends. Over shorter timeframes, the weakness is pronounced: the stock declined 1.24% over the past week and sits down 28.99% year-to-date, a substantial underperformance relative to the S&P 500's 3.84% year-to-date gain. The one-year picture is similarly negative, with ARES down 21.36% compared to the broader market's 32.23% appreciation. This extended underperformance traces partly to worse-than-expected Q4 2025 earnings results released in early February, which triggered an 11.2% stock decline and signaled operational challenges.
Despite the current weakness, Ares Management maintains operational strength that supports a more constructive longer-term thesis. The company reported a robust 18.63% average return on equity and has delivered positive results across the last three consecutive quarters, demonstrating solid execution in asset management and operations. Year-to-date net sales and operating profit growth remain impressive, providing fundamental support for the valuation case.
Analyst sentiment reflects this tension between near-term headwinds and longer-term fundamentals. Argus recently lowered its 12-month price target to $107.00, consistent with current price weakness, while other rating houses maintain "Buy" recommendations with 12-month targets around $141.71, implying approximately 25.40% upside from current trading levels. This variance in outlooks underscores ongoing uncertainty regarding the timing and magnitude of a potential recovery for the alternative asset manager as macro conditions and capital market activity evolve through mid-2026.
The stock's performance reveals a stark divergence between near-term and long-term trends. Over shorter timeframes, the weakness is pronounced: the stock declined 1.24% over the past week and sits down 28.99% year-to-date, a substantial underperformance relative to the S&P 500's 3.84% year-to-date gain. The one-year picture is similarly negative, with ARES down 21.36% compared to the broader market's 32.23% appreciation. This extended underperformance traces partly to worse-than-expected Q4 2025 earnings results released in early February, which triggered an 11.2% stock decline and signaled operational challenges.
Despite the current weakness, Ares Management maintains operational strength that supports a more constructive longer-term thesis. The company reported a robust 18.63% average return on equity and has delivered positive results across the last three consecutive quarters, demonstrating solid execution in asset management and operations. Year-to-date net sales and operating profit growth remain impressive, providing fundamental support for the valuation case.
Analyst sentiment reflects this tension between near-term headwinds and longer-term fundamentals. Argus recently lowered its 12-month price target to $107.00, consistent with current price weakness, while other rating houses maintain "Buy" recommendations with 12-month targets around $141.71, implying approximately 25.40% upside from current trading levels. This variance in outlooks underscores ongoing uncertainty regarding the timing and magnitude of a potential recovery for the alternative asset manager as macro conditions and capital market activity evolve through mid-2026.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.